Table 2. Plasmids, primers, and oligonucleotides used in this work.
Plasmida | Residue alterations | Primer sets |
---|---|---|
pRR536 | Wild-type Gln31–730-Myc13 | 5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ |
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR658b | Gln3NES mam. | 5′-CAATCGGCCGCTGGAAAAGACCGCAGGCATTGCAAAGAGT-3 |
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
5′-CAATCGGCCGTCGGACGTTATCAAAAAGAGGATTTCAAAG-3 | ||
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT- 3′ | ||
5′-GGCCGAATGAATTAGCCTTGAAATTAGCAGGTCTTGATATCAACAAGACAC-3′ | ||
5′-GGCCGTGTCTTGTTGATATCAAGACCTGCTAATTTCAAGGCTAATTCATTC-3′ | ||
pRR702b | Gln310–20Δ | 5′-CAATCGGCCGCTTCGAATTTTCGGGGTCGTCTTGCATTTG-3′ |
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ | ||
5′-CAATCGGCCGCATGGTCGAAGTAATGAAGAGCCGAG-3′ | ||
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR714b | Gln364–73Δ | 5′-CAATCGGCCGACGGACTTCGTGTCTCCTTTTACAGCAGC-3′ |
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ | ||
5′-CAATCGGCCGCATTGAGTCGAATGTGCCGCCGTTTAATCC-3′ | ||
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR752c | Gln3L64D,L67R,L71D,F73D-Myc13 | 5′-CAATCGGCCGGATGATgacTATgacACGGACTTCGTG-3′ |
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ | ||
5′-CAATCGGccgTGCCTCgtcCATTGAGTCGAATGTGCCGCC-3′ | ||
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR787 | Gln3L332D,L336D,M340D,L343D-Myc13 | 5′-CAATCGGCCGatcGGTACCATGgtcTTTCTGGAAatcACCGCAGGCATTGCAAAGAG-3′ |
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ | ||
5′-CAATCGGCCGgacTCCTTAAAATCGGACGTTATCAAAAAG-3′ | ||
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR1090c | Gln3L64A,L67R,L71A,F73A-Myc13 | 5′-CAATCGGCCGGATGATgcaTATgctACGGACTTCGTGTCTCC-3′ |
5′-CGCGGATCCTATACCAAATTTTAACCAATCCAATTCGTCAGCAATTGCT-3′ | ||
5′-CAATCGGccgTGCCTCtgcCATTGAGTCGAATGTGCCGCCG-3′ | ||
5′-ATCCCCGCGGGACGTCAACTCCATAGAAGTGACTTTTCCG-3′ | ||
pRR1215 | Gln3M340D,L343D,L345D-Myc13 | 5′-TTACATGGTACCgacAGGCCAgacTCCgacAAATCGGACGTTATCAAAAAG-3′ |
5′-CGGAACAACAGATCTGGATGAAGATTTACTGGAACTTG-3′ | ||
pRR1217 | Gln3M340A,L343A,L345A-Myc13 | 5′-TTACATGGTACCgcgAGGCCAgcaTCCgcaAAATCGGACGTTATCAAAAAG-3′ |
5′-CGGAACAACAGATCTGGATGAAGATTTACTGGAACTTG-3′ | ||
DAL3-5 | DAL3 promoter oligonucleotide | 5′-tcgacTGGATTGGCAAATAAATGGGGAAAGATAAGCGAGATAAGACTGATAAGAAG |
CATATGCGGTCTATTCATGg-3′ | ||
5′-cCATGAATAGACCGCATATGCTTCTTATCAGTCTTATCTCGCTTATCTTTCCCCATT | ||
TATTTGCCAATCCAgtcga-3′ | ||
pAA15 | NLS-LexA-URE2 | Structure in Kulkarni et al. (2001) |
pRS316 | Vector | Structure in http://genome-www.stanford.edu/vectordb/vector_descrip/COMPLETE/PRS316.SEQ.html |
All plasmids contain full-length gln3 genes driven by the native GLN3 promoter.
An EagI site, encoding arginine and proline, replaced the deleted amino acids.
The L67R substitution was required for the cloning strategy we employed.